Rapid lateral flow immunoassay for qualitative detection of SARS-CoV-2 antigens. Enables quick point-of-care testing for COVID-19 diagnosis.
Manufactured by
Nanjing, Jiangsu, China
Jiangsu Medomics Medical Technology Co., Ltd., founded in October 2017, is located at Biotech and Pharmaceutical Valley of the National Jiangbei New Area, Nanjing, Jiangsu Province. It is an international high-tech enterprise driven by innovation in the area of medical devices R D, production and sales. Medomics focuses on diagnosis of microorganisms, tumors and some rare diseases, mainly engaged in the research and development, production and sales of in vitro diagnostic reagents and automatic instruments. Medomics owns two R D centers in China and the US, independent intellectual property rights of fluorescent staining technology, protein labeling technology, time-resolved immunofluorescence detection technology, image processing and analysis technology and other innovative technology platforms, as well as a total of more than 2,000 square meters of GMP purification production workshop that meets the product standards of FDA, CE and CFDA. Medomics also has a multidisciplinary expert team with abundant experience in the industry, including senior experts in immunology, microbiology, applied physics, polymer materials, medical imaging, optical systems, etc. The members of the technical team are led by doctors from many famous institutions, such as Osaka University, North Carolina University, University of Nebraska Lincoln, Zhejiang University, Sichuan University and other institutions. At the very beginning of COVID-19 on early 2020, Medomics developed IgM/IgG antibody detecting kit with the team of Zhong Nanshang. And Medomics published the first research paper on international journal together with State Key Laboratory of Respiratory Disease (National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health). The detecting kit was validated by CDC, Harvard Medical School and Columbia University Irving Medical Center etc. Until May 2020, the kit has been exported to dozens of countries and areas, making great help against SARS-Cov-2. At present, Medomics s series products of SARS-Cov-2 detection have been developed according to ISO 13485 Quality System and European CE Certification.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Guangzhou Labsim Medical Diagnostics Co., Ltd.
China · 2 relevant products
Biopanda Reagents
United Kingdom · 1 relevant product
Biosci Healthcare
India · 1 relevant product
Qingdao Hightop Biotech Co., Ltd
China · 1 relevant product
Dialab GmbH
Austria · 1 relevant product
AEHEALTH Limited
China · 1 relevant product
BioTeke Corporation(wuxi) Co.,Ltd
China · 1 relevant product
HANGZHOU SINGCLEAN MEDICAL PRODUCTS CO., LTD
China · 1 relevant product
Hangzhou Lysun Biotechnology Co.,Ltd
China · 1 relevant product
J. Mitra & Co. Pvt. Ltd.
India · 1 relevant product
74 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →9 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 110 closest product alternatives
Guangzhou Labsim Medical Diagnostics Co., Ltd. · China
A rapid test kit for the detection of SARS-CoV-2 antigens using lateral flow immunoassay technology. This kit provides quick results for COVID-19 diagnosis.
Biopanda Reagents · United Kingdom
Lateral flow immunoassay for rapid detection of SARS-CoV-2 antigen in respiratory specimens. Provides quick results for point-of-care COVID-19 diagnosis in clinical and laboratory settings.
Biosci Healthcare · India
Rapid point-of-care test kit for quick and accurate detection of SARS-CoV-2 antigens. Designed for use in clinical settings and resource-limited environments to enable fast diagnostic decision-making.
Qingdao Hightop Biotech Co., Ltd · China
SARS-CoV-2 antigen rapid test kit designed for self-testing, enabling quick detection of COVID-19 infection in point-of-care settings. This lateral flow immunoassay delivers results within minutes using a nasal or oropharyngeal specimen, providing accessible screening for symptomatic individuals and contact tracing programs.
Dialab GmbH · Austria
Rapid antigen test kit for qualitative detection of SARS-CoV-2 in clinical specimens. Designed for point-of-care and laboratory testing with fast turnaround time. Enables quick identification of active COVID-19 infection to support clinical decision-making and infection control.
AEHEALTH Limited · China
Rapid immunoassay-based test for SARS-CoV-2 antigen detection. Enables quick screening and diagnostic confirmation for COVID-19.
BioTeke Corporation(wuxi) Co.,Ltd · China
Rapid antigen test kit for SARS-CoV-2 detection, designed for point-of-care diagnostic applications. The kit enables quick identification of active COVID-19 infection through antigen detection methodology, supporting clinical decision-making in healthcare settings.
HANGZHOU SINGCLEAN MEDICAL PRODUCTS CO., LTD · China
Rapid test kit for detecting SARS-CoV-2 antigens. Provides point-of-care diagnosis for COVID-19 infection.
Hangzhou Lysun Biotechnology Co.,Ltd · China
A rapid visual immunoassay for qualitative detection of SARS-CoV-2 antigens. Designed for self-testing and point-of-care diagnosis of COVID-19 infection.
J. Mitra & Co. Pvt. Ltd. · India
Rapid antigen detection kit for SARS-CoV-2. Provides quick point-of-care testing for COVID-19 diagnosis.
Hecin Scientific, Inc. · China
A rapid diagnostic test kit for detection of SARS-CoV-2 antigens. This antigen-based test enables quick identification of COVID-19 infections in clinical settings.
Nanjing Leading Medical Technology Co. Ltd. · China
Rapid antigen detection test for identifying current SARS-CoV-2 infection. Designed for point-of-care testing applications in clinical and screening settings.
98 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products